Turning long-form videos such as podcasts, interviews, or even scripted episodes into short, shareable clips has been, to this point, a tedious and manual task. But thanks to AI, that is changing – fast.
In fact, Captions promises a much more robust editing suite than both Opus Clip and Riverside with control over visual effects like transitions and zoom as well as giving editors the ability to remove backgrounds and tweak the look and feel of footage.
All three of these platforms are finding success. Captions boasts over three million creators, 100,000 active users, and closed $25 million in Series B funding in June. Opus Clip has managed to pull in 400,000 users in just one month which shows massive growth over such a short period of time. Riverside has been in the game since 2020 and is one of the biggest names in the online podcasting space and continues to grow.
Given the market can sustain these three companies — and very likely more — it is safe to assume this market segment is poised to continue to grow. One thing doe seem certain: AI is making manual editing of social media clips, and perhaps all video editing at some point, a thing of the past.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make BillionsBenjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins to tackle a wide range of diseases–and it’s garnered deals with Big Pharma potentially worth over $4 billion.
Baca lebih lajut »
Is the iPad Pro worth it for photo editing?The iPad Pro is pricey, but it could be perfect for editing your nature snaps and astrophotography on the go.
Baca lebih lajut »
‘Unrecognizable’ Teresa Giudice called out for editing photo: ‘You look zero like that’“Omg Teresa enough with the FaceTune.. you look like a cartoon character,” one fan commented under a picture of the “Real Housewives of New Jersey” star.
Baca lebih lajut »
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make BillionsBenjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins to tackle a wide range of diseases–and it’s garnered deals with Big Pharma potentially worth over $4 billion.
Baca lebih lajut »
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make BillionsBenjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins to tackle a wide range of diseases–and it’s garnered deals with Big Pharma potentially worth over $4 billion.
Baca lebih lajut »
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make BillionsBenjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion
Baca lebih lajut »